Cargando…
Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer’s Disease Framework
BACKGROUND: The most significant biomarkers that are included in the Alzheimer’s disease (AD) research framework are amyloid-β plaques deposition, p-tau, t-tau, and neurodegeneration. Although cerebrospinal fluid (CSF) biomarkers are included in the most recent AD research criteria, their use is inc...
Autores principales: | Gallucci, Maurizio, Cenesi, Leandro, White, Céline, Antuono, Piero, Quaglio, Gianluca, Bonanni, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108561/ https://www.ncbi.nlm.nih.gov/pubmed/35180122 http://dx.doi.org/10.3233/JAD-215432 |
Ejemplares similares
-
Staging Alzheimer’s Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers
por: Chen, Guangyu, et al.
Publicado: (2016) -
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016) -
Lights and Shadows in Hepatic Encephalopathy Diagnosis
por: Amodio, Piero, et al.
Publicado: (2021) -
Lights and Shadows
Publicado: (1897) -
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
por: McGrowder, Donovan A., et al.
Publicado: (2021)